Wockhardt Limited (WOCKPHARMA.NS)
INR 1319.15
(9.91%)
INR 1319.15
(9.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.48 Billion INR | -49.82% |
| 2022 | 16.9 Billion INR | -10.68% |
| 2021 | 18.92 Billion INR | 2.57% |
| 2020 | 18.44 Billion INR | 5.05% |
| 2019 | 17.55 Billion INR | -25.48% |
| 2018 | 23.56 Billion INR | 0.51% |
| 2017 | 23.44 Billion INR | -5.29% |
| 2016 | 24.75 Billion INR | -0.25% |
| 2015 | 24.81 Billion INR | 7.32% |
| 2014 | 23.12 Billion INR | 5.87% |
| 2013 | 21.84 Billion INR | 15.29% |
| 2012 | 18.94 Billion INR | 31.03% |
| 2011 | 14.45 Billion INR | 1.32% |
| 2010 | 14.27 Billion INR | -21.78% |
| 2009 | 18.24 Billion INR | 20.33% |
| 2008 | 15.16 Billion INR | 39.25% |
| 2007 | 10.88 Billion INR | 1.41% |
| 2006 | 10.73 Billion INR | 32.89% |
| 2005 | 8.07 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.74 Billion INR | -24.02% |
| 2023 Q1 | 3.99 Billion INR | -3.39% |
| 2023 Q2 | 4.49 Billion INR | 12.53% |
| 2023 FY | 8.48 Billion INR | -49.82% |
| 2023 Q4 | 2.29 Billion INR | -43.03% |
| 2023 Q3 | 4.02 Billion INR | -10.47% |
| 2022 Q3 | 3.86 Billion INR | -12.87% |
| 2022 Q4 | 4.13 Billion INR | 6.99% |
| 2022 FY | 16.9 Billion INR | -10.68% |
| 2022 Q1 | 4.48 Billion INR | -0.87% |
| 2022 Q2 | 4.43 Billion INR | -1.12% |
| 2021 Q2 | 4.77 Billion INR | -3.03% |
| 2021 Q4 | 4.51 Billion INR | -3.76% |
| 2021 FY | 18.92 Billion INR | 2.57% |
| 2021 Q1 | 4.92 Billion INR | 13.74% |
| 2021 Q3 | 4.69 Billion INR | -1.7% |
| 2020 Q1 | 4.99 Billion INR | 72.91% |
| 2020 FY | 18.44 Billion INR | 5.05% |
| 2020 Q4 | 4.33 Billion INR | -6.08% |
| 2020 Q3 | 4.61 Billion INR | 2.27% |
| 2020 Q2 | 4.5 Billion INR | -9.69% |
| 2019 Q1 | 5.09 Billion INR | -5.27% |
| 2019 Q3 | 4.66 Billion INR | -4.91% |
| 2019 Q4 | 2.88 Billion INR | -38.12% |
| 2019 FY | 17.55 Billion INR | -25.48% |
| 2019 Q2 | 4.9 Billion INR | -3.72% |
| 2018 Q3 | 6.03 Billion INR | -3.43% |
| 2018 FY | 23.56 Billion INR | 0.51% |
| 2018 Q4 | 5.38 Billion INR | -10.84% |
| 2018 Q1 | 5.89 Billion INR | -5.11% |
| 2018 Q2 | 6.25 Billion INR | 5.98% |
| 2017 FY | 23.44 Billion INR | -5.29% |
| 2017 Q3 | 5.5 Billion INR | -4.88% |
| 2017 Q4 | 6.21 Billion INR | 12.99% |
| 2017 Q2 | 5.78 Billion INR | 3.74% |
| 2017 Q1 | 5.57 Billion INR | -12.83% |
| 2016 Q2 | 5.91 Billion INR | 1.75% |
| 2016 Q4 | 6.39 Billion INR | 10.62% |
| 2016 Q3 | 5.78 Billion INR | -2.27% |
| 2016 FY | 24.75 Billion INR | -0.25% |
| 2016 Q1 | 5.81 Billion INR | 1.23% |
| 2015 Q2 | 6.43 Billion INR | 11.29% |
| 2015 Q1 | 5.77 Billion INR | -21.7% |
| 2015 FY | 24.81 Billion INR | 7.32% |
| 2015 Q4 | 5.74 Billion INR | -4.67% |
| 2015 Q3 | 6.02 Billion INR | -6.32% |
| 2014 Q4 | 7.38 Billion INR | 37.08% |
| 2014 Q3 | 5.38 Billion INR | 15.41% |
| 2014 FY | 23.12 Billion INR | 5.87% |
| 2014 Q2 | 4.66 Billion INR | -18.07% |
| 2014 Q1 | 5.69 Billion INR | 1.62% |
| 2013 Q1 | 5.07 Billion INR | -6.65% |
| 2013 Q3 | 5.69 Billion INR | 4.08% |
| 2013 FY | 21.84 Billion INR | 15.29% |
| 2013 Q4 | 5.6 Billion INR | -1.59% |
| 2013 Q2 | 5.47 Billion INR | 7.82% |
| 2012 Q3 | 4.99 Billion INR | 9.57% |
| 2012 Q2 | 4.55 Billion INR | 14.95% |
| 2012 Q1 | 3.96 Billion INR | 23.93% |
| 2012 FY | 18.94 Billion INR | 31.03% |
| 2012 Q4 | 5.43 Billion INR | 8.9% |
| 2011 Q4 | 3.19 Billion INR | -13.45% |
| 2011 FY | 14.45 Billion INR | 1.32% |
| 2011 Q3 | 3.69 Billion INR | 0.0% |
| 2010 FY | 14.27 Billion INR | -21.78% |
| 2009 FY | 18.24 Billion INR | 20.33% |
| 2008 FY | 15.16 Billion INR | 39.25% |
| 2007 FY | 10.88 Billion INR | 1.41% |
| 2006 FY | 10.73 Billion INR | 32.89% |
| 2005 FY | 8.07 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 46.565% |
| Hester Biosciences Limited | 908.84 Million INR | -833.058% |
| Aarti Drugs Limited | 1.16 Billion INR | -626.351% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -175.826% |
| Albert David Limited | 1.02 Billion INR | -726.392% |
| Alembic Limited | 872.45 Million INR | -871.967% |
| Alkem Laboratories Limited | 32.83 Billion INR | 74.174% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -1761.343% |
| Bajaj HealthCare Limited | 985.34 Million INR | -760.612% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -124240.176% |
| Brooks Laboratories Limited | 51.18 Million INR | -16468.972% |
| Eris Lifesciences Limited | 4.94 Billion INR | -71.558% |
| FDC Limited | 3.49 Billion INR | -142.302% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 27.152% |
| Gufic Biosciences Limited | 1.18 Billion INR | -614.654% |
| Hikal Limited | 4.46 Billion INR | -89.973% |
| Ind-Swift Limited | 946.56 Million INR | -795.869% |
| Innova Captab Limited | 931.03 Million INR | -810.819% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -285.279% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -1833.645% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 41.331% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -689.435% |
| Lupin Limited | 125.09 Billion INR | 93.221% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -5127.211% |
| Medico Remedies Limited | 59.67 Million INR | -14110.306% |
| Morepen Laboratories Limited | 1.98 Billion INR | -326.677% |
| Nectar Lifesciences Limited | 932.7 Million INR | -809.188% |
| Orchid Pharma Limited | 800.77 Million INR | -958.979% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -183.101% |
| RPG Life Sciences Limited | 1.63 Billion INR | -418.496% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -1956.121% |
| Sigachi Industries Limited | 579.88 Million INR | -1362.354% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -232.015% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -504.51% |
| Themis Medicare Limited | 1.12 Billion INR | -653.243% |
| Unichem Laboratories Limited | 6.72 Billion INR | -26.08% |
| Vaishali Pharma Limited | 84.02 Million INR | -9991.754% |
| Wanbury Limited | 978.96 Million INR | -766.22% |
| Windlas Biotech Limited | 1 Billion INR | -742.515% |
| ZIM Laboratories Limited | 1.01 Billion INR | -737.07% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -299.212% |
| Ipca Laboratories Limited | 18.98 Billion INR | 55.339% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 94.5% |
| Venus Remedies Limited | 1.91 Billion INR | -342.523% |
| Sakar Healthcare Limited | 204.07 Million INR | -4055.254% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 84.764% |
| Divi's Laboratories Limited | 14.17 Billion INR | 40.155% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -242.834% |
| Mankind Pharma Limited | 29.27 Billion INR | 71.031% |
| Sequent Scientific Limited | 2.9 Billion INR | -192.231% |
| Laurus Labs Limited | 11.9 Billion INR | 28.798% |
| Neuland Laboratories Limited | 2.92 Billion INR | -189.445% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 42.674% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 81.939% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 93.227% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -304.959% |
| Bal Pharma Limited | 555.62 Million INR | -1426.206% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 91.155% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -497.51% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -14448.444% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -289.975% |
| Shilpa Medicare Limited | 3.33 Billion INR | -154.336% |
| Valiant Laboratories Limited | 138.02 Million INR | -6043.636% |
| Ajanta Pharma Limited | 30.46 Billion INR | 72.163% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -59563.688% |
| Granules India Limited | 10.31 Billion INR | 17.772% |
| Medicamen Biotech Limited | 335.16 Million INR | -2430.082% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -2353.469% |
| Piramal Enterprises Limited | 63.65 Billion INR | 86.678% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 60.415% |
| NATCO Pharma Limited | 10.05 Billion INR | 15.689% |
| Suven Life Sciences Limited | 109.75 Million INR | -7626.651% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -18272.476% |
| Strides Pharma Science Limited | 9.16 Billion INR | 7.447% |
| Indoco Remedies Limited | 12.06 Billion INR | 29.692% |
| Alpa Laboratories Limited | 127.38 Million INR | -6557.246% |
| Lasa Supergenerics Limited | 291.17 Million INR | -2812.348% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -175.611% |